Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

THOMAS ELDRIDGE STINCHCOMBE

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1265510416
CMS profile
330185
Location
CHAPEL HILL, NC

General Payments · PY2018–2024

$277,115.89

  • Reported across 278 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$36,827.28

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $31,833.04 16
Honoraria $2,825.00 3
Travel and Lodging $1,195.88 5
Food and Beverage $973.36 13

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $22,042.21 43
PY2019 $63,855.29 70
PY2020 $56,402.51 45
PY2021 $41,058.26 21
PY2022 $22,406.00 23
PY2023 $34,524.34 39
PY2024 $36,827.28 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Acrotech Biopharma Inc. $162.84 11/07/2024 Food and Beverage Undisputed 01/23/2026 1147106232 CMS
Acrotech Biopharma Inc. $474.95 11/07/2024 Travel and Lodging Undisputed 01/23/2026 1147106234 CMS
Acrotech Biopharma Inc. $219.69 11/07/2024 Travel and Lodging Undisputed 01/23/2026 1147106236 CMS
Acrotech Biopharma Inc. $15.98 11/12/2024 Food and Beverage Undisputed 01/23/2026 1147106238 CMS
Acrotech Biopharma Inc. $56.38 11/12/2024 Travel and Lodging Undisputed 01/23/2026 1147106240 CMS
Acrotech Biopharma Inc. $4,500.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 1147106242 CMS
Acrotech Biopharma Inc. $0.01 12/09/2024 Consulting Fee Undisputed 01/23/2026 1147106244 CMS
AstraZeneca Pharmaceuticals LP $66.15 02/21/2024 Food and Beverage Undisputed 01/23/2026 1110554958 CMS
AstraZeneca Pharmaceuticals LP $32.86 11/23/2024 Food and Beverage Undisputed 01/23/2026 1110540953 CMS
Boehringer Ingelheim International GmbH $650.00 01/19/2024 Consulting Fee Undisputed 01/23/2026 1117939882 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,220.00 11/19/2024 Consulting Fee Undisputed 01/23/2026 1117939884 CMS
Coherus Biosciences Inc. $1,200.00 06/12/2024 Honoraria Undisputed 01/23/2026 1147277236 CMS
Daiichi Sankyo Inc. $26.84 10/01/2024 Food and Beverage Undisputed 01/23/2026 1089486922 CMS
E.R. Squibb & Sons, L.L.C. $1,480.00 12/05/2024 Consulting Fee Undisputed 01/23/2026 1101289336 CMS
F. Hoffmann-La Roche AG $1,900.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1133124690 CMS
Gilead Sciences, Inc. $3,820.00 01/11/2024 Consulting Fee Undisputed 01/23/2026 1133600055 CMS
GlaxoSmithKline, LLC. $1,300.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1115985998 CMS
GlaxoSmithKline, LLC. $1,300.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1116412275 CMS
Janssen Biotech, Inc. $102.40 11/22/2024 Food and Beverage Undisputed 01/23/2026 1078819963 CMS
Janssen Biotech, Inc. $1,800.00 12/06/2024 Consulting Fee Undisputed 01/23/2026 1078819425 CMS
Janssen Research & Development, LLC $4,610.53 06/20/2024 Consulting Fee Undisputed 01/23/2026 1077589899 CMS
Merck Sharp & Dohme LLC $1,372.50 10/30/2024 Consulting Fee Undisputed 01/23/2026 1141744627 CMS
PFIZER INC. $133.68 02/22/2024 Food and Beverage Undisputed 01/23/2026 1131614909 CMS
PFIZER INC. $1,575.00 03/15/2024 Consulting Fee Undisputed 01/23/2026 1131611519 CMS
PFIZER INC. $975.00 05/24/2024 Honoraria Undisputed 01/23/2026 1131614905 CMS
PFIZER INC. $650.00 08/16/2024 Honoraria Undisputed 01/23/2026 1131614901 CMS
PFIZER INC. $1,705.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1131611523 CMS
PFIZER INVESTMENT CO., LTD $13.05 08/02/2024 Food and Beverage Undisputed 01/23/2026 1131607322 CMS
PFIZER INVESTMENT CO., LTD $13.21 08/14/2024 Food and Beverage Undisputed 01/23/2026 1131607318 CMS
PFIZER INVESTMENT CO., LTD $16.86 08/17/2024 Food and Beverage Undisputed 01/23/2026 1131607310 CMS
PFIZER INVESTMENT CO., LTD $27.99 08/17/2024 Food and Beverage Undisputed 01/23/2026 1131607314 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,800.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1144968298 CMS
Takeda Pharmaceuticals U.S.A., Inc. $222.43 04/04/2024 Travel and Lodging Undisputed 01/23/2026 1144968300 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,800.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1144968302 CMS
Takeda Pharmaceuticals U.S.A., Inc. $222.43 04/04/2024 Travel and Lodging Undisputed 01/23/2026 1144968304 CMS
Takeda Pharmaceuticals U.S.A., Inc. $118.28 05/06/2024 Food and Beverage Undisputed 01/23/2026 1144968306 CMS
Takeda Pharmaceuticals U.S.A., Inc. $243.22 05/09/2024 Food and Beverage Undisputed 01/23/2026 1144968308 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.